3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
178
Lung Neoplasms
56
NSCLC
11
Neoplasms
10
Neoplasm Metastasis
9
Brain Neoplasms
8
Carcinoma
7
Bronchial Neoplasms
5
Thoracic Neoplasms
4
Colorectal Neoplasms
4
Respiratory Tract Neoplasms
3
Respiratory Tract Diseases
3
Neoplasms by Site
3
Meningeal Carcinomatosis
3
Lung Diseases
3
Carcinoma, Squamous Cell
3
Breast Neoplasms
3
Adenocarcinoma of Lung
3
Adenocarcinoma
3
Uterine Neoplasms
2
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Noonan Syndrome
2
Non Small Cell Lung Cancer Metastatic
2
Neoplasms, Nerve Tissue
2
Neoplasms by Histologic Type
2
Carcinoma, Bronchogenic
2
Triple Negative Breast Neoplasms
1
Interventions
Etoposide
156
Carboplatin
146
Cisplatin
106
Topotecan
76
durvalumab
52
atezolizumab
51
Irinotecan
45
pembrolizumab
39
Paclitaxel
34
Nivolumab
33
Radiotherapy
31
PM 01183
25
Drug Therapy
24
anlotinib
23
Gemcitabine
21
apatinib
19
Ipilimumab
18
Docetaxel
17
Temozolomide
16
Platinum
16
Radiosurgery
15
Pemetrexed
14
toripalimab
13
tislelizumab
13
olaparib
13
Magnetic Resonance Spectroscopy
13
Bevacizumab
13
rovalpituzumab tesirine
11
amrubicin
11
Specimen Handling
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
osimertinib
×
Thoracic
×
Clear all
NCT07153055
2025-12-18
LOTS
Indiana University
Phase 1/2
Not yet recruiting
16 enrolled